A caller exertion allows scientists to map, successful azygous cells, nan DNA binding sites of transcription factors and different regulatory proteins that power cistron activity, according to a study led by investigators astatine Weill Cornell Medicine and nan New York Genome Center. With cardinal advantages complete methods presently successful use, nan exertion is expected to beryllium a powerful summation to biologists' toolkit for studying cells successful wellness and disease.
"D&D-seq," arsenic nan caller method is called, uses antibodies to bring a DNA-editing enzyme adjacent to a target protein, allowing researchers to grounds wherever that macromolecule interacts pinch DNA. The study describing nan technique, published June 4 successful Cell, showed that it surmounts cardinal method drawbacks of existent methods for mapping protein-DNA interactions, and is nan first of its benignant that tin beryllium easy incorporated into high-throughput, single-cell "multi-omics" workflows.
"A batch of investigation has been held backmost because we didn't person nan correct devices for mapping DNA-protein interactions successful azygous cells; and now that we person specified a instrumentality location is tremendous excitement—it's really a foundational technological advance," said study co-senior writer Dr. Dan Landau, nan Bibliowicz Family Professor of Medicine and a personnel of the Sandra and Edward Meyer Cancer Center and nan Englander Institute for Precision Medicine at Weill Cornell. Dr. Landau is besides a halfway module personnel of nan New York Genome Center.
The study's different co-senior writer is Dr. Ivan Raimondi, elder molecular biologist and investigation invention head successful nan Landau Lab. Wei-Yu Chi, a doctoral campaigner successful nan Weill Cornell Graduate School of Medical Sciences and Dr. Sang-Ho Yoon, a postdoctoral subordinate successful medicine successful nan Landau lab, are nan co-first authors connected nan paper.
Multi-omics refers to mixed analyses of different layers of accusation wrong cells, including DNA sequences (genomes), cistron activity patterns (transcriptomes), and macromolecule populations (proteomes). What is sometimes called nan regulome covers transcription factors and different proteins that hindrance to DNA to move genes "on" aliases "off."
These regulatory proteins are known to beryllium critically important successful biology. A ample proportionality of nan disease-risk hotspots identified successful genetics studies dishonesty astatine transcription facet binding sites. Yet nan devices disposable for mapping existent transcription facet DNA-binding events successful cells, including superior cells taken from patients, person had important limitations. These see a comparative insensitivity to anemic aliases transient binding events, and an incompatibility pinch different modular multi-omics tools—an incompatibility that tin make it difficult to get nan large image of really a cistron aliases gene-network is regulated.
D&D-seq takes its sanction from nan docking of a macromolecule of liking to a deaminase enzyme, followed by mean sequencing. Even a transient binding of nan deaminase-linked macromolecule to DNA will time off a people that tin beryllium detected successful sequencing data.
DNA is simply a marvelous molecule for signaling and storing information, and we are exploiting this spot to our advantage."
Dr. Ivan Raimondi, elder molecular biologist
The researchers demonstrated D&D-seq's imaginable by utilizing it to representation nan binding sites of respective transcription factors arsenic good arsenic chromatin remodeling proteins, which power cistron activity by locally opening aliases closing nan twisted building of DNA. The demonstrations included a mapping of nan DNA binding sites of a cardinal transcription facet successful humor cells, comparing cells pinch and without a communal leukemia mutation—and enabling nan researchers to spot successful item really nan mutation changes nan transcription facet binding.
"We're entering an era of medicine successful which transcription factors and different gene-activity regulators will progressively beryllium therapeutic targets," said Dr. Landau, who is besides an oncologist astatine NewYork-Presbyterian/Weill Cornell Medical Center. "This benignant of exertion should person an important domiciled successful processing and evaluating specified therapies."
The researchers showed that D&D-seq—though a activity successful progress, pinch galore improvements planned—can already beryllium utilized pinch modular single-cell multi-omics platforms, allowing nan mapping of DNA-protein interactions alongside related readouts of cistron activity patterns, wide genome sequences and different "-omic" layers successful individual cells.
"D&D-seq is platform-agnostic—it's fundamentally a plug-and-play characteristic that you tin adhd to existing platforms to get much accusation from your experiments," Dr. Raimondi said.
Drs. Landau and Raimondi expect a wide take of D&D-seq for multi-omics-based research. They are already training researchers from different labs successful its usage and purpose to commercialize nan approach, Dr. Landau said.
Source:
Journal reference:
Chi, W.-Y., et al. (2026). Single-cell mapping of regulatory DNA-protein interactions. Cell. DOI: 10.1016/j.cell.2026.05.014. https://www.cell.com/cell/fulltext/S0092-8674(26)00573-8
English (US) ·
Indonesian (ID) ·